Skip to main navigation Skip to search Skip to main content

Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer

  • Daniele Vergara
  • , Claudia Bellomo
  • , Xingcai Zhang
  • , Viviana Vergaro
  • , Andrea Tinelli
  • , Vito Lorusso
  • , Ross Rinaldi
  • , Yuri M. Lvov
  • , Stefano Leporatti
  • , Michele Maffia
  • Università del Salento
  • Giovanni Paolo II Hospital
  • NNL-Istituto Nanoscienze
  • Institute for Micromanufacturing
  • Vito Fazzi Hospital
  • Consiglio Nazionale delle Ricerche

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)891-899
Number of pages9
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume8
Issue number6
DOIs
StatePublished - Aug 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • General Materials Science
  • Pharmaceutical Science

Keywords

  • Lapatinib
  • Nanocapsules
  • Ovarian cancer
  • Paclitaxel
  • Sonication-assisted Layer-by-Layer

Fingerprint

Dive into the research topics of 'Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer'. Together they form a unique fingerprint.

Cite this